Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Vivitrol in Alcoholism
NCT00156923Phase 3Completed
- Sponsor
- Alkermes
- Start
- Oct 2003
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
Phase 3, double-blind trial of naltrexone in alcohol use disorder (AUD) (2 arms), sponsored by Alkermes. Primary endpoint: Number of Participants Reporting at Least 1 Treatment-emergent Adverse Event up to 3.5 years. Started Oct 2003; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00156923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156923.